Cortical Blindness:Etiology, Diagnosis, & Prognosis
Ann Neurol 21:149-158, Aldrich,M.S.,et al, 1987
Carotid Occlusive Disease, Effect of Bright Light on Visual Evoked Response
Arch Neurol 39:687-689, Donnan,G.A.,et al, 1982
Central Achromatopsia:Behavioral, Anatomic, & Physiologic Aspects
Neurol 30:1064-1071, Damasio,A.,et al, 1980
"Better Explanations" in Multiple Sclerosis Diagnostic Workup
Neurol 92:e2527-e2537, Calabrese, M.,et al, 2019
Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017
Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009
Early Visual Function Impairment in CADASIL
Neurol 60:2008-2010, Parisi,V.,et al, 2003
Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001
Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
A Man Who Lost Weight and His Sight
Lancet 351:1174-1175, Moschos,M.&Droutsas,D., 1998
Charcot-Marie-Tooth Neuropathies:From Clinical Description to Molecular Genetics
Muscle & Nerve 18:267-275995., Ionasecu,V.V., 1995
Visual System Abnormalities in Adrenomyeloneuropathy
Ann Neurol 37:550-552, Kaplan,P.W.,et al, 1995
Visual Evoked Potential in Adrenoleukodystrophy:Glycerol Trioleate and Lorenzo Oil
Ann Neurol 34:169-174, 1211993., Kaplan,P.W.,et al, 1993
Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Frequent Involvement of the Optic Radiation in Patients with Acute Isolated Optic Neuritis
Neurol 42:77-79, Hornabrook,R.S.L.,et al, 1992
Symptomatic Retrochiasmal Lesions in MS:Clinical Features, Visual Evoked Potentials, and Magnetic Resonanc Imaging
Neurol 42:68-76, Plant,G.T.,et al, 1992
Evoked Potentials in Cerebrotendinous Xanthomatosis and Effect Induced by Chenodeoxycholic Acid
Arch Neurol 49:469-475, Mondelli,M.,et al, 1992
Abnormalities in Color Vision and Contrast Sensitivity in Parkinson's Disease
Neurol 42:887-890, Price,M.J.,et al, 1992
Effects of Intravent Hemorrhage & Socioecon Status on NEur Status of Low Birth Weight Inf at 5 yrs of age
J Pediatr 121:280-285, Vohr,B.,et al, 1992
The Diagnostic Reliability of Magnetically Evoked Motor Potentials In Multiple Sclerosis
Neurol 42:1296-1301, Ravnborg,M.,et al, 1992
Lidocaine Unmasks Silent Demyelinative Lesions in Multiple Sclerosis
Neurol 42:2088-2093, Sakurai,M.,et al, 1992
Longitudinal Neurophysiologic Studies in Pt with Metachromatic Leukodystrophy Following Bone Marrow Trnspl
Arch Neurol 49:1088-1092, Dhuna,A.,et al, 1992
No Confirmation of Visual Evoked Potential Diagnostic Test for Migraine
Lancet 337:517-518, vanDijk,J.G.,et al, 1991
The Sensitivity of Transcranial Cortical Magnetic Stimulation in Detecting Pyramidal Tract Lesions in Clin Definite MS
Neurol 41:566-569, Mayr,N.,et al, 1991
Reversal of a Neurologic Paraneoplastic Syndrome with Octreotide (Sandostatin) in a Pt with Glucagonoma
Am J Med 91:434-436, Holmes,A.,et al, 1991
Hallervorden-Spatz Syndrome and Brain Iron Metabolism
Arch Neurol 48:1285-1293, Swaiman,K.F., 1991
Visual Evoked Responses in Children with Migraine:A Diagnostic Test
Lancet 335:75-77, Mortimer,M.J.,et al, 1990
Neurologic & Evoked Potential Abnormalities in Subtle Cobalamin Deficiency States
Arch Neurol 47:1008-1012, Karnaze,D.S.&Carmel,R., 1990
Vision and Hearing During Deferoxamine Therapy
J Pediatr 117:326-330, Cohen,A.,et al, 1990
Optic Neuritis:A Prospective Study
Neurol 40:919-923, Celesia,G.G.,et al, 1990
Neurosarcoidosis:Signs, Course and Treatment in 35 Confirmed Cases
Medicine 69:261-276, Chapelon,C.,et al, 1990
Infantile CNS Spongy Degeneration-14 Cases:Clinical Update
Neurol 40:1876-1882, Gascon,G.G.,et al, 1990
Chronic Myelopathies Associated with HTLV-I, A Clinical, Serologic, and Immunovirologic Study of 10 Patients in France
Arch Neurol 46:255-260, Gout,O.,et al, 1989
Disturbance of Cerebral Function by Aluminium in Haemodialysis Patients without Overt Aluminium Toxicity
Lancet 2:7-12, Altmann,P.,et al, 1989
Visual Evoked Potentials and Nonfunctioning Pituitary Tumours
Editorial, Lancet 1:883-8841989., , 1989
Cerebrospinal Fluid Immunoglogulins & MS, Correspondence MRI & Visually Evoked Potential Changes
Arch Neurol 46:367-371, Miller,F.A.J.,et al, 1989
Subacute Combined Degeneration of the Spinal Cord
In Rowland's, Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 691, Mancall,E.L., 1989
MRI in the Diagnosis of MS:Comparison of Clinical Eval, Evoked Potentials, Oligoclonal Banding, & CT
Neurol 38:180-185, 309-3141988., Paty,D.W.,et al, 1988
Evoked Potentials in Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 45:1014-1016, Pakalnis,A.,et al, 1988
Value of Visual Evoked Response & Oligoclonal Bands in CSF, In Diagnosis of Spinal Multiple Sclerosis
Lancet 1:769-771, Kempster,P.A.,et al, 1987
Cranial Magnetic Resonance Imaging in the Evaluation of Myelopathy of Undetermined Etiology
Neurol 37:840-843, Miska,R.M.,et al, 1987
Serial Visual Evoked Potential Recordings in Alzheimer's Disease
BMJ 293:9-10, Orwin,A.,et al, 1986
Visual & Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
NEJM 314:869-873, Olivieri,N.F.,et al, 1986
Multiple Sclerosis:Magnetic Resonance Imaging, Evoked Responses, & Spinal Fluid Electroporesis
Neurol 36:828-831, Farlow,M.R.,et al, 1986
Adult Metachromatic Leukodystrophy:Neurophysiologic Findings
Neurol 35:1776-1778, Wulff,C.H.&Trojaborg,W., 1985
The Value of Visual Evoked Potential as a Screening Test in Neurofibromatosis
Arch Neurol 42:1072-1074, Jabbari,B.,et al, 1985